Ivan S F Chan Selected Research

Herpes Zoster Vaccine

1/2018	Inactivated varicella zoster vaccine in autologous haemopoietic stem-cell transplant recipients: an international, multicentre, randomised, double-blind, placebo-controlled trial.
3/2015	Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of age.
3/2015	Long-term persistence of zoster vaccine efficacy.
11/2014	Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curve.
8/2013	Safety of zoster vaccine in elderly adults following documented herpes zoster.
4/2013	Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications.
9/2010	Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults.
6/2010	Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster.
4/2010	Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses.
10/2009	Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ivan S F Chan Research Topics

Disease

20	Herpes Zoster 01/2019 - 08/2004
5	Chickenpox 01/2018 - 04/2002
4	Postherpetic Neuralgia 03/2015 - 08/2004
3	Neoplasms (Cancer) 01/2019 - 12/2005
3	Infections 01/2018 - 04/2010
3	Exanthema (Rash) 01/2017 - 08/2004
3	Pain (Aches) 09/2012 - 08/2004
2	Injection Site Reaction 01/2019 - 04/2013
1	Opportunistic Infections (Opportunistic Infection) 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Vaginal Diseases 02/2015
1	Staphylococcal Infections 04/2013
1	Mental Disorders (Mental Disorder) 04/2013
1	Major Depressive Disorder (Major Depressive Disorders) 04/2013
1	Radiculopathy (Radiculopathy, Cervical) 11/2011
1	Uveitis 11/2011
1	Sciatica (Sciatic Neuralgia) 11/2011
1	Communicable Diseases (Infectious Diseases) 03/2011
1	Human Influenza (Influenza) 10/2007
1	Pruritus (Itching) 11/2006
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 12/2003
1	Hepatitis B 08/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2002
1	Breakthrough Infections 04/2002

Drug/Important Bio-Agent (IBA)

22	VaccinesIBA 01/2019 - 04/2002
13	Herpes Zoster VaccineIBA 01/2018 - 02/2007
4	EnzymesIBA 09/2012 - 04/2002
4	Chickenpox Vaccine (Vaccine, Varicella)IBA 04/2010 - 04/2002
3	Glycoproteins (Glycoprotein)IBA 10/2007 - 04/2002
3	ImmunosorbentsIBA 10/2007 - 04/2002
2	AntibodiesIBA 01/2018 - 04/2002
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Monoclonal AntibodiesIBA 01/2017
1	Papillomavirus Vaccines (HPV Vaccines)IBA 02/2015
1	V710 vaccineIBA 04/2013
1	Antidepressive Agents (Antidepressants)IBA 04/2013
1	Interferon-gamma (Interferon, gamma)IBA 09/2012
1	Pharmaceutical PreparationsIBA 03/2011
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 11/2010
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 08/2002
1	Surface Antigens (Surface Antigen)IBA 08/2002
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 08/2002

Therapy/Procedure

3	Activities of Daily Living (ADL) 09/2010 - 08/2004
1	Drug Therapy (Chemotherapy) 01/2019
1	Transplantation 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017
1	Pain Management 12/2005
1	Lenses 12/2003